MCM2 and hepatocellular carcinoma: Therefore, the anticancer potential of MST-321 against high-STMN1-expressing HCC cells may result from its inhibitory effect on DNA replication (MCM2/5/6) and mitosis (BUB1B, TTK, STMN1).